US 6,306,900 B1Granted

Enteric coated pharmaceutical compositions

AssigneeNovartis AG

InventorsBarbara Haeberlin, Ching-Pong Mak, Armin Meinzer, Jacky Vonderscher

Life of this patent

Estimating the term…

Abstract

This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.

Claims14

Dependent claims

A pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to prevent release of mycophenolate in the stomach.

Dependencies are inferred from the claim text.

Facts

Application: 09/694,209Filed 23 Oct 2000 · continuation
Priority: GB 960756412 Apr 1996
Granted: 23 Oct 2001
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/365
Having oxygen as the only ring hetero atom, e.g. fungichromin: lactones
A61K 9/4891
Preparations in capsules, e.g. of gelatin, of chocolate: coated capsules; Multilayered drug free capsule shells
A61K 38/13
Cyclic peptides , e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C: cyclosporins
A61P 29/00
Non-central analgesic, antipyretic or antiinflammatory agents

Family

PCT/EP97/01800Parent of this continuation · filed 10 Apr 1997
Application09/469,536Parent of this continuation · filed 22 Dec 1999
US 6,172,107 B2Parent of this continuation
Application09/077,398Parent of this continuation
US 6,025,391 AParent of this continuation
US 6,306,900 B1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results